JSJames P. Scarth

James P. Scarth

*This is an algorithmically generated author record based on publicly available information.

James P. Scarth has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A review of analytical strategies for the detection of ‘endogenous’ steroid abuse in food production

    by J. P. Scarth, J. Kay, P. Teale, C. Akre, B. Le Bizec, H. F. De Brabander, L. Vanhaecke, L. Van Ginkel, J. Points

    Detection of the abuse of synthetic steroids in food production is nowadays relatively straightforward using modern techniques such as gas or liquid chromatography coupled to mass spectrometry (GC‐MS/MS or LC‐MS/MS, respectively). However, proving the abuse of ‘endogenous’ (or naturally occurring) steroids is more difficult. Despite these difficulties, significant progress in this area has recently been made and a number of methods are now available.The aim of the current review was to systematically review the available analytical approaches, which include threshold concentrations, qualitative ‘marker’ metabolites, intact steroid esters, gas chromatography‐combustion‐isotope ratio mass spectrometry (GC‐C‐IRMS), longitudinal testing and ‘omics’ biomarker profiling. The advantages/disadvantages of these methods are considered in detail, but the choice of which to adopt is dictated by a number of practical, political, and economic factors, which vary in different parts of the world. These include the steroid/species combination requiring analysis, the matrix tested, whether samples are collected from live or slaughtered animals, available analytical instrumentation, sample throughput/cost, and the relevant legal/regulatory frameworks. Furthermore, these approaches could be combined in a range of different parallel and/or sequential screening/confirmatory testing streams, with the final choice being determined by the aforementioned considerations.Despite these advances, more work is required to refine the different techniques and to respond to the ever increasing list of compounds classified as ‘endogenous’. At this advanced stage, however, it is now more important than ever for scientists and regulators from across the world to communicate and collaborate in order to harmonize and streamline research efforts. © 2012 HFL Sport Science (LGC Ltd) and © Her Majesty the Queen in Right of Canada.


  • UPLC-MS/MS Method for the Identification of Recombinant Human Erythropoietin Analogues in Horse Plasma and Urine

    by James P. Scarth, Cathrin Seibert, Pamela R. Brown, Phil Teale, Gavin J. Beamon, Clive M. Pearce, Richard A. Sams


  • Detection of endogenous steroid abuse in cattle: results from population studies in the UK

    by J.P. Scarth, A. Clarke, P. Teale, A. Mill, R. Macarthur, J. Kay

    The use of steroids as growth-promoting agents in food production is banned under European Union legislation. Detecting the abuse of testosterone, nandrolone, boldenone, oestradiol and progesterone is complicated by the fact that these steroids are known to be endogenous in certain situations. In this study, the concentrations of characteristic metabolites of each of these steroids were quantified in populations of untreated steers and heifers. Steroid concentration population data were then used by a statistical model (the Chebyshev inequality) to produce threshold concentrations for screening and confirming the abuse of these steroids in steer and non-pregnant heifer urine. In addition to thresholds based on testing one animal (a ‘1 out of 1’ approach), new methods based on testing multiple animals from a herd (a ‘y out of n’ approach) allowed threshold concentrations to be significantly reduced and hence false compliances to be minimised. In the majority of cases, the suggested thresholds were found to be capable of confirming the abuse of endogenous steroids in steers and heifers. In the case of oestradiol abuse in the female, however, confirmation based on a threshold is not possible and alternative methods such as gas chromatography-combustion-isotope ratio mass spectrometry are required. In addition to the steer and heifer populations, a small number of pregnant animals were also tested, yielding insights into the biosynthetic pathways of some of the steroids.


  • Drug metabolism in the horse: a review

    by James P. Scarth, Phil Teale, Tiia Kuuranne

    A detailed understanding of equine drug metabolism is important for detection of drug abuse in horseracing and also in veterinary drug development and practice. To date, however, no comprehensive review of equine drug metabolism has been published.The majority of literature regarding equine drug metabolite profiles is derived from sports drug detection research and is generally targeted at detecting marker metabolites of drug abuse. However, the bulk of the literature on equine drug metabolism enzymology is derived from veterinary studies aimed at determining the molecular basis of metabolism. In this article, the phase 1 and 2 metabolisms of seven of the most important classes of drugs monitored in horseracing are reviewed, including: anabolic‐androgenic steroids (AAS), β2‐agonists, stimulants, sedatives/tranquilizers, local anesthetics, non‐steroidal anti‐inflammatory analgesics (NSAIDS)/cyclooxygenase‐2 (COX‐2) inhibitors, and opioid analgesics. A summary of the literature relating to the enzymology of drug metabolism in this species is also be presented.The future of equine drug metabolism in the area of doping research will be influenced by several factors, including: a possible move towards the increased use of blood and other alternative testing matrices; the development of assays based on intact drug conjugates; the increasing threat of ‘designer’ and herbal‐ based products; advances in the use ofin vitrotechnologies; the increased use of liquid‐chromatography/high‐resolution mass spectrometry; and the possibility of screening using ‘omics’ approaches. Also, the recent cloning of a range of equine cytochrome P450 (CYP) enzymes opens up the potential for carrying out more detailed mechanistic pharmacological and toxicological veterinary studies. Copyright © 2010 John Wiley & Sons, Ltd.


  • Validation of an Analytical Biomarker Approach for the Detection of Nandrolone Abuse in the Porcine

    by James P. Scarth, Adam Clarke, Jonathan Hands, Philip Teale, Aileen C. Mill, Roy Macarthur, Jack Kay, Hubert Brabander


  • The use ofin vitrotechnologies coupled with high resolution accurate mass LC‐MS for studying drug metabolism in equine drug surveillance

    by James P. Scarth, Holly A. Spencer, Sarah E. Timbers, Simon C. Hudson, Lynn L. Hillyer

    The detection of drug abuse in horseracing often requires knowledge of drug metabolism, especially if urine is the matrix of choice. In this study, equine liver/lung microsomes/S9 tissue fractions were used to study the phase I metabolism of eight drugs of relevance to equine drug surveillance (acepromazine, azaperone, celecoxib, fentanyl, fluphenazine, mepivacaine, methylphenidate and tripelennamine).In vitrosamples were analyzed qualitatively alongside samples originating fromin vivoadministrations using LC‐MS on a high resolution accurate mass Thermo Orbitrap Discovery instrument and by LC‐MS/MS on an Applied Biosystems Sciex 5500 Q Trap.Using high resolution accurate mass full‐scan analysis on the Orbitrap, thein vitrosystems were found to generate at least the two most abundant phase I metabolites observedin vitrofor all eight drugs studied. In the majority of cases,in vitroexperiments were also able to generate the minorin vivometabolites and sometimes metabolites that were only observedin vitro. More detailed analyses of fentanyl incubates using LC‐MS/MS showed that it was possible to generate good quality spectra from the metabolites generatedin vitro. These data support the suggestion of usingin vitroincubates as metabolite reference material in place ofin vivopost‐administration samples in accordance with new qualitative identification guidelines in the 2009 International Laboratory Accreditation Cooperation‐G7 (ILAC‐G7) document.In summary, thein vitroandin vivophase I metabolism results reported herein compare well and demonstrate the potential ofin vitrostudies to compliment, refine and reduce the existing equinein vivoparadigm. Copyright © 2010 John Wiley & Sons, Ltd.


  • The application of in vitro technologies to study the metabolism of the androgenic/anabolic steroid stanozolol in the equine

    by James P. Scarth, Holly A. Spencer, Simon C. Hudson, Philip Teale, Bob P. Gray, Lynn L. Hillyer


  • Presence and metabolism of endogenous androgenic–anabolic steroid hormones in meat-producing animals: a review

    by J. Scarth, C. Akre, L. van Ginkel, B. Le Bizec, H. De Brabander, W. Korth, J. Points, P. Teale, J. Kay

    The presence and metabolism of endogenous steroid hormones in meat-producing animals has been the subject of much research over the past 40 years. While significant data are available, no comprehensive review has yet been performed. Species considered in this review are bovine, porcine, ovine, equine, caprine and cervine, while steroid hormones include the androgenic–anabolic steroids testosterone, nandrolone and boldenone, as well as their precursors and metabolites. Information on endogenous steroid hormone concentrations is primarily useful in two ways: (1) in relation to pathological versus ‘normal’ physiology and (2) in relation to the detection of the illegal abuse of these hormones in residue surveillance programmes. Since the major focus of this review is on the detection of steroids abuse in animal production, the information gathered to date is used to guide future research. A major deficiency in much of the existing published literature is the lack of standardization and formal validation of experimental approach. Key articles are cited that highlight the huge variation in reported steroid concentrations that can result when samples are analysed by different laboratories under different conditions. These deficiencies are in most cases so fundamental that it is difficult to make reliable comparisons between data sets and hence it is currently impossible to recommend definitive detection strategies. Standardization of the experimental approach would need to involve common experimental protocols and collaboratively validated analytical methods. In particular, standardization would need to cover everything from the demographic of the animal population studied, the method of sample collection and storage (especially the need to sample live versus slaughter sampling since the two methods of surveillance have very different requirements, particularly temporally), sample preparation technique (including mode of extraction, hydrolysis and derivatization), the end-point analytical detection technique, validation protocols, and the statistical methods applied to the resulting data. Although efforts are already underway (at HFL and LABERCA) to produce more definitive data and promote communication among the scientific community on this issue, the convening of a formal European Union working party is recommended.